EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
PASW
Ping An Biomedical Co., Ltd.
There isn't enough reported data to score PASW yet.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PASW Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
PASW's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
PASW PE Valuation
PASW has no meaningful PE right now: it lost money over the past year.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PASW Forward outlook
There aren't enough analyst estimates for PASW to show an outlook.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
EOSE is still losing money, but less than at its worst: $4.55 per share over the past year, against $8.73 at its worst in late 2021.
PASW Earnings Per Share
PASW and EOSE do not have enough comparable growth data to identify a winner.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE's revenue has grown year over year for 10 quarters in a row: $83M last quarter, up 171% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was โ96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
PASW Quarterly Revenue
PASW and EOSE do not have enough comparable growth data to identify a winner.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -70% | N/A |
| Q1 2025 | -20% | N/A |
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: โ$443M over the past year, against โ$246M the year before.
PASW Free Cash Flow
PASW and EOSE do not have enough comparable growth data to identify a winner.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PASW Net Leverage
PASW's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PASW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 13.7 | Oversold |
| Stochastic | 13.3 | Oversold |
PASW's weekly RSI is 14 (oversold) and its Stochastic is 13 (oversold).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
PASW PE vs Industrials Sector
PASW has no meaningful PE right now: it lost money over the past year.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
PASW has stronger trend alignment. EOSE is above 0 of 5 weekly averages versus PASW above 0 of 3.
PASW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.06 | 62% below |
| 20 week MA | $4.89 | 68% below |
| 50 week MA | $7.60 | 79% below |
PASW is in a downtrend: it's below all three of its weekly moving averages, and 79% below its 50-week average.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE has the edge over PASW on returns for 2026, with the stronger performance.
PASW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $132.0 | $25.5 | -81% |
| 2026 YTD | $25.5 | $1.56 | -94% |
PASW has finished every year since 2025 lower, and it's down 94% so far in 2026.